NM_001086521.2:c.195+271C>T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_001086521.2(NDUFAF8):c.195+271C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000729 in 536,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001086521.2 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFAF8 | NM_001086521.2 | c.195+271C>T | intron_variant | Intron 2 of 2 | ENST00000431388.3 | NP_001079990.1 | ||
NDUFAF8 | NM_001353402.1 | c.199+267C>T | intron_variant | Intron 2 of 2 | NP_001340331.1 | |||
NDUFAF8 | NM_001353403.1 | c.37+6C>T | splice_region_variant, intron_variant | Intron 2 of 2 | NP_001340332.1 | |||
NDUFAF8 | NR_148426.1 | n.36C>T | non_coding_transcript_exon_variant | Exon 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000611 AC: 93AN: 152220Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.000775 AC: 298AN: 384294Hom.: 0 Cov.: 3 AF XY: 0.000863 AC XY: 175AN XY: 202684
GnomAD4 genome AF: 0.000611 AC: 93AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000457 AC XY: 34AN XY: 74370
ClinVar
Submissions by phenotype
Mitochondrial complex 1 deficiency, nuclear type 34 Pathogenic:5
- -
- -
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with mitochondrial complex I deficiency, nuclear type 34 (MIM#618776). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0209 - Splice site variant proven to affect splicing of the transcript with uncertain effect on protein sequence. Functional analysis of patient fibroblasts shows this variant results in intron retention and the loss of isoform 2. However, the exact protein outcome is unclear as this would be expected to result in a truncated protein (PMID: 31866046). (SP) 0252 - This variant is homozygous. (I) 0304 - Variant is present in gnomAD (v3) <0.01 for a recessive condition (93 heterozygotes, 0 homozygotes). (SP) 0705 - No comparable intronic variants have previous evidence for pathogenicity. (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been described as likely pathogenic and pathogenic, and observed in two unrelated compound heterozygous individuals with Leigh syndrome and complex I deficiency (ClinVar, PMID: 31866046). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Variant summary: C17ORF89 (NDUFAF8) c.195+271C>T is located at a position not widely known to affect splicing. However, several computational tools predict a significant impact on normal splicing: Three predict the variant strengthens a cryptic intronic 5 donor site. Experimental evidence demonstrated this variant was associated with an mRNA defect leading to loss of the functionally relevant transcript (Alston_2020). The variant allele was found at a frequency of 0.00062 in 150992 control chromosomes, predominantly at a frequency of 0.0012 within the Non-Finnish European subpopulation in the gnomAD v3.1.1 database. Due to an unknown prevalence of C17ORF89 associated Mitochondrial Complex 1 Deficiency, this frequency relative to that expected for a pathogenic variant in C17ORF89 is unknown, allowing no conclusion about variant significance. c.195+271C>T has been reported in the literature in two comprehensively genotyped compound heterozygous individuals affected with Mitochondrial Complex 1 Deficiency (Alston_2020). Experimental evidence derived from studies on fibroblasts and muscle cells from one of these individuals indicated a decrease in complex I activity, a reduction in oxidative capacity, decreased levels of fully assembled complex I and a generalized reduction in complex I subunits (Alston_2020). These data indicate that the variant may be associated with disease. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
NDUFAF8-related disorder Pathogenic:1
The NDUFAF8 c.199+267C>T variant is predicted to interfere with splicing. This variant, also reported as c.195+271C>T in transcript NM_001086521, has been reported in two unrelated individuals with a clinical diagnosis of Leigh syndrome (subjects 1 and 2, Alston et al. 2019. PubMed ID: 31866046). In vitro studies from subject 1's fibroblast cells demonstrated expression of this variant results in aberrant splicing, a reduction in oxidative capacity, as well as decreased levels of fully assembled complex I in both muscle cells and fibroblasts compared to controls (Figures S3, S4 and 3, Alston et al. 2019. PubMed ID: 31866046). Additionally, a rescue assay demonstrated that this phenotype could be corrected by a reintroduction of wildtype (Figure 3, Alston et al. 2019. PubMed ID: 31866046). This variant is reported in 0.12% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. -
Mitochondrial disease Pathogenic:1
- -
not provided Pathogenic:1
NDUFAF8: PM3:Strong, PM2, PS3:Supporting -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at